ArticleAnimals : an open access journal from MDPI2026
Effects of Compound Milk Oligosaccharides on Growth Performance, Immune Function, and Intestinal Health of Neonatal Suckling Piglets with Different Birth Weights.
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This experiment was conducted to investigate the effects of compound milk oligosaccharides (CMO) on growth performance, immune function, and intestinal health of neonatal suckling piglets with different birth weights. Forty neonatal suckling piglets (20 piglets with normal birth body weight (NBW), 20 piglets with low birth body weight (LBW)) from 10 lactating sows with the same parity and litter size (2 normal birth weight piglets and 2 low birth weight piglets from each sow), were allotted to one of four treatments (10 replications with 1 piglet per treatment) in a 2 × 2 factorial design, including two birth body weight (normal or low birth weight) and two CMO doses (0 or 75 mg/d). All piglets were orally administered 2 mL CMO solution (37.5 mg/mL CMO, with a ratio of 3' SL:2' FL:6' SL = 5:4:1) or equivalent volume saline daily, from birth until day 21 of age. At the end of the trial, eight piglets per treatment were used for terminal serum and intestinal measurements, and five piglets per treatment were used for colonic microbiota analysis. As expected, NBW piglets had higher body weight and average daily gain than LBW littermates (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.